Results 71 to 80 of about 88,040 (166)

Aniridia‐associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets

open access: yesActa Ophthalmologica, Volume 104, Issue 6, Page 604-615, September 2026.
Abstract Congenital aniridia is a rare genetic disorder primarily caused by pathogenic variants of the PAX6 gene. It leads to various panocular anomalies, including aniridia‐associated keratopathy (AAK). This review highlights recent insights into its pathogenesis, focusing on clinical staging, microstructural changes in the cornea and molecular ...
N. Szentmáry   +27 more
wiley   +1 more source

Comportamiento Clínico Epidemiológico del Glaucoma Neovascular en un Servicio de Glaucoma

open access: yesArchivo Médico de Camagüey, 2009
Fundamento: Entre las enfermedades oculares, el glaucoma, está contemplado entre aquellas que más cambios han sufrido en muchos de sus variados aspectos con el decursar de los años.
Matilde Landín Sorí   +2 more
doaj  

Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications

open access: yesClinical Ophthalmology
Asem A Alqudah, Ahmed G Obaidi, Mohammad Al Zoubi, Abdelwahab Aleshawi Division of Ophthalmology, Department of Special Surgery, Jordan University of Science and Technology, Irbid, 22110, JordanCorrespondence: Asem A Alqudah, Ophthalmology Service ...
Alqudah AA   +3 more
doaj  

Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma

open access: yesClinical Ophthalmology, 2011
Christopher C Shen1, Sarwat Salim2, Haiming Du2, Peter A Netland31Glaucoma Consultants Northwest, Seattle, WA, USA; 2University of Tennessee Health Science Center, Memphis, TN, USA; 3University of Virginia School of Medicine, Charlottesville, VA ...
Christopher C Shen   +3 more
doaj  

Purtscher's retinopathy followed by neovascular glaucoma

open access: yes, 2013
Masasko Kuroda,1 Akihiro Nishida,1 Masashi Kikuchi,2 Yasuo Kurimoto11Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan; 2Kikuchi Eye Clinic, Kobe, Hyogo, JapanAbstract: We report the case of a 66-year-old Japanese
Kikuchi M   +3 more
core  

Estrategia de intervención sanitaria en pacientes con glaucoma neovascular

open access: yesHumanidades Médicas, 2012
En el trabajo se muestra el diseño de una estrategia de intervención sanitaria en pacientes con glaucoma neovascular. Se aborda la necesidad del cambio del pensamiento sanitario del predominio biológico y curativo al enfoque integral con énfasis en la ...
Matilde Landín Sorí   +1 more
doaj   +2 more sources

Molteno drainage implant for neovascular glaucoma

open access: yes, 1982
Neovascular glaucoma is the most difficult form of glaucoma and responds poorly to medical treatment and conventional filtering procedures. Neovascular glaucoma most commonly occurs after a central retinal vein occlusion or in association with ...
Ancker E., Molteno A.C.B.
core  

Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report a case of refractory glaucoma secondary to iris metastasis from breast cancer which was successfully treated with intravitreal bevacizumab.
Stephanie Vale   +3 more
doaj   +1 more source

Use of Anti-VEGF Agents in Glaucoma Surgery

open access: yesJournal of Ophthalmology, 2017
A number of antivascular endothelial growth factor agents are currently used to treat ocular conditions. These agents have similar but distinct biologic qualities and have each been used in the management of neovascular glaucoma and in glaucoma surgery ...
Mark Slabaugh, Sarwat Salim
doaj   +1 more source

Cyclocryotherapy in neovascular glaucoma treatment [PDF]

open access: yes, 2012
The main goal in the struggle with neovascular glaucoma is to control intraocular pressure (IOP) and pain. 152 patients, e.g., 203 eyes, were examine at the Clinic of Ophthalmology, Clinical Centre of Kragujevac, Serbia, in period between 01. 01.
Tatjana Šarenac   +4 more
core  

Home - About - Disclaimer - Privacy